Mark J. Holdbrook - Mar 17, 2023 Form 4 Insider Report for Tarsus Pharmaceuticals, Inc. (TARS)

Role: V.P., Clinical Affairs
Signature: /s/ Leonard M. Greenstein, Attorney-in-Fact
Stock symbol: TARS
Transactions as of: Mar 17, 2023
Transactions value $: -$4,993
Form type: 4
Date filed: 3/21/2023, 07:06 PM
Previous filing: Mar 17, 2023

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	TARS	Common Stock	Sale	-$2.5K	-188	-5.26%	$13.28	3.39K	Mar 17, 2023	Direct	F1
transaction	TARS	Common Stock	Sale	-$2.5K	-198	-5.84%	$12.61	3.19K	Mar 20, 2023	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Mark J. Holdbrook is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may continue.

Explanation of Responses:

Id	Content
F1	The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of Restricted Stock Units. The sale is mandated by the Issuer's election to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction by the Reporting Person.

Content

The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of Restricted Stock Units. The sale is mandated by the Issuer's election to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction by the Reporting Person.